Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens
Aim. To study infectious complications and factors attributable to them as reported in multiple myeloma (MM) patients in the framework of state-of-the-art anticancer therapy. Materials & Methods. The study included MM patients who received regimens based on bortezomib, lenalidomide, and bendamu...
Main Authors: | AA Novikova, GA Klyasova, EO Gribanova, VV Ryzhko, TA Tupoleva, LP Mendeleeva, VG Savchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2019-03-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: |
http://bloodjournal.ru/wp-content/uploads/2019/03/14-1.pdf
|
Similar Items
-
Infectious complications in patients with multiple myeloma on first chemotherapy cycle
by: A. A. Novikova, et al.
Published: (2018-10-01) -
The Use of Pomalidomide in the Treatment of Relapsed/Refractory Multiple Myeloma in Patients with Renal Failure
by: IG Rekhtina, et al.
Published: (2018-10-01) -
Optimization of regimes of mobilization of blood hemopoietic stem cells in patients with multiple myeloma
by: Ol'ga Stanislavovna Pokrovskaya, et al.
Published: (2011-07-01) -
Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma
by: MV Firsova, et al.
Published: (2019-09-01) -
DARATUMUMAB FOR THE TREATMENT OF MULTIPLE MYELOMA
by: V. V. Ryzhko, et al.
Published: (2017-11-01)